Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Uterine Cervical Neoplasms 1Respiratory Aspiration 1Pain 1Ovarian Neoplasms 1Meningioma 1Hemorrhage 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease 1Breast Self-Examination 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 16Hydroxyurea 7Everolimus 7Bevacizumab 7lutetium Lu 177 dotatate 6gallium Ga 68 dotatate 6Proton Therapy 6Specimen Handling 5pembrolizumab 4Surgical Procedures, Operative 4Radiosurgery 4Imatinib Mesylate 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4aldesleukin 3abemaciclib 3Tranexamic Acid 3Temozolomide 3Sunitinib 3Sodium Chloride 3Radiotherapy, Intensity-Modulated 3Radiotherapy 3Nivolumab 3Ga(III)-DOTATOC 390Y-octreotide, DOTA-Tyr(3)- 3vistusertib 2trametinib 2ribociclib 2fludarabine 2arginyllysine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Meningioma × Sensitivity Training Groups × Clear all
NCT04386642 2021-01-27

Tranexamic Acid Reduce Blood Loss in Meningioma Resection

Chiang Mai University

Phase 4 Unknown
44 enrolled
CNS

Hemorrhage, Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡